Month: May 2020

 May 4, 2020 Dear Shareholders and Investors,Dear Sirs,In our message to you of March 24, 2020, we declared a dividend of 14 cents for 1Q 2020. This is double the dividend for 4Q 2019. For 1Q 2019, the declared dividend was 3 cents.We have now a dividend history of 91 consecutive quarters. Below is a link to our dividend table since the first payment in 1997, totalling close to USD 50 per share in dividend.NAT Dividends  CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTSMatters discussed in this press release may constitute forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides safe harbor protections for forward-looking statements in order to encourage companies to provide prospective information about their business. Forward-looking statements include statements concerning plans, objectives,...

SPARTA, N.J., May 04, 2020 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on developing its clinically validated and patent-protected PLxGuard™ delivery system to provide more effective and safer products, VAZALORE™ 325 mg and VAZALORE™ 81 mg (referred to together as “VAZALORE”™), announced today that the Company will release its 2020 first quarter financial results on Friday, May 15, 2020, before the U.S. financial markets open.Natasha Giordano, President and Chief Executive Officer, and Rita O’Connor, Chief Financial Officer, will host a conference call to discuss the results as follows:A replay of the conference call will be available for two weeks after the call’s completion by dialing (855) 859-2056 (U.S.) or (404) 537-3406 (International)....

WAYNE, Pa., May 04, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.  The dividend is payable June 15, 2020 to shareholders of record at the close of business on May 15, 2020.  Additional information about Teleflex can be obtained from the company’s website at www.teleflex.com.About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency...

CAMBRIDGE, Mass., May 04, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from cancer, today announced the appointment of Stephen Webster to its Board of Directors. With nearly 30 years of biotechnology industry experience in raising capital, business development transactions and operations, Mr. Webster has played important roles as the Chief Financial Officer of Spark Therapeutics, Optimer Pharmacuticals and Adolor Corporation. In connection with Mr. Webster’s arrival, Mitchell Finer, Ph.D., will be stepping down from the Board of Directors effective May 4, 2020 but will continue to serve TCR2 in an advisory capacity.“We are delighted to welcome in another successful cell and gene therapy executive...

Paris, le 4 mai 2020Modalités de mise à disposition du Document d’enregistrement universel 2019incluant le rapport financier annuelLe Document d’enregistrement universel d’Ipsos relatif à l’exercice clos le 31 décembre 2019, comprenant également le rapport financier annuel, a été déposé le 30 avril 2020 auprès de l’Autorité des Marchés Financiers (« l’AMF »), sous le numéro D.20-0418.Ce document peut être consulté ou téléchargé sur les sites internet d’Ipsos (https://www.ipsos.com/en/regulated-informations/fr) et de l’AMF (http://www.amf-france.org).Des exemplaires du Document d’enregistrement universel sont disponibles au siège de la société : 35, rue du Val de Marne – 75013 Paris.Le Document d’enregistrement universel inclut notamment :le rapport financier annuel 2019, constitué des comptes consolidés, des comptes annuels, du...

For Immediate ReleaseHelsinki – May 4, 2020 – In connection with the national Post-Quantum Cryptography project, Business Finland has awarded SSH.COM a 1.3 million Euro grant for developing quantum-safe crypto technology. In addition to SSH.COM, the consortium comprises leading Finnish cybersecurity companies and research institutions, as well as international partners. Key national security agencies also participate in the project.The project is a part of the Digital Trust Finland program by Business Finland focused on driving collaboration between Finnish companies and the globally growing market of digital trust-based business models and solutions. The program supports also supports the assessment of the opportunities and threats posed by new technologies such as quantum computing.The project consists of several work packages that...

Välittömästi julkaisuvapaaHelsinki – 4.5.2020 – Osana kansallista Post-Quantum Cryptography -hanketta Business Finland on myöntänyt SSH.COM:ille 1,3 miljoonaa euroa tuotekehitysavustusta kvanttiturvallisten salausteknol­ogioiden kehittämiseen. Konsortioon kuuluu SSH.COM:in lisäksi joukko johtavia kotimaisia tietoturva-alan yrityksiä ja tutkimuslaitoksia sekä kansainvälisiä kumppaneita. Hankkeessa on mukana myös kansallisen turvallisuuden kannalta keskeisiä viranomaisia.Hanke on osa Business Finlandin Digital Trust -ohjelmaa, jonka tavoitteena on Suomen luottamus­pääomaa hyödyntäen kiihdyttää uusien innovaatioiden syntyä ja liiketoiminnan kasvua: turvallisuuden ja luottamuksen ratkaisuissa ja -palveluissa sekä ratkaisutoimittajien että hyödyntäjien näkökulmasta. Ohjelma tukee uusien teknologioiden, kuten kvanttilaskennan mahdollisuuksien...

PLANO, Texas, May 04, 2020 (GLOBE NEWSWIRE) — Denbury Resources Inc. (NYSE: DNR) (“Denbury” or the “Company”) today announced that due to the ongoing public health impact of the coronavirus pandemic (COVID-19) and to support the health and well-being of our stockholders, the Board of Directors of the Company has decided that it will be hosting its 2020 Annual Meeting of Stockholders (“Annual Meeting”) in a virtual only format.  No stockholders or guests will be able to attend the Annual Meeting in person.The Annual Meeting will be held on its originally scheduled date, Thursday, May 28, 2020, at 8:00 A.M. Central Daylight Time (CDT).  Stockholders of record on March 31, 2020, will be able to attend the virtual Annual Meeting by going to www.virtualshareholdermeeting.com/DNR2020 and entering the control number found on their proxy...

WAYNE, Pa., May 04, 2020 (GLOBE NEWSWIRE) — Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the UBS Virtual Global Healthcare Conference on Monday, May 18, 2020 at 10:50 a.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine,...

Investeringsforeningen Handelsinvest har opdateret CI-dokumenter og følgende afdelinger har skiftet risikoprofil:Handelsinvest DanmarkHandelsinvest EuropaHandelsinvest NordenHandelsinvest VerdenHandelsinvest VirksomhedsobligationerHandelsinvest Defensiv 30De ajourførte versioner fremgår på foreningens hjemmeside www.handelsinvest.dk.                            Venlig hilsenHandelsinvest